The VC secondaries specialist reached the $850m hard-cap for its predecessor, which held its final close in 2021.
Core Ventures Fund I's LPs include state and city public pension funds, foundations and endowments, funds of funds, hospital and health systems, sovereign wealth funds and family offices.
James Gettinger, co-founder of Gutter Capital, discusses the firm's $25 million debut fund and how venture capital is like betting on fantasy sports.
More than 90% of LPs say they require impact funds to perform in-line or better than their generalist private equity benchmark, according to a survey by Rede Partners.
A well-established venture firm missing its fundraising target signals that some LPs are cutting back on their commitment sizes.
European healthcare investor EQT Life Sciences has closed its inaugural LSP Dementia Fund at €260 million euros, beating its target of €100 million.
OpenView set an ambitious target for Fund VII, aiming for a nearly 80% increase from Fund VI, which closed in October 2020.
The New York firm raised a debut fund of $25m to invest in companies that address affordability, economic mobility and climate change.
Torch Capital's focus on consumer products appears to have lit a fire with investors, as the New York venture firm has closed on more than $200 million, or three times more than it raised for its debut fund.
Sofinnova Partners, a European life sciences venture capital firm, has launched a new investment strategy focused on digital medicine.